PTK2 and ovarian carcinoma: For example, it was found that inhibition of FAK and c‐Myc synergized to suppress ovarian cancer cell growth38; and c‐Myc and FAK functioned together to promote invasion of skin cancer cells.39 Our study uncovered a novel biochemical crosstalk between c‐Myc and FAK activation in HCC cells in response to Dasatinib.